Liposomal bupivacaine is one of 141 small molecule programs targeting Total Knee Arthroplasty. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
77 competitors in Chronic Pain
Voltaren
Duragesic
MS Contin
Dolophine
Precedex
Tylenol
Marcaine
Decadron
Prilosec
Lodosyn
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details